Top Markets
Coin of the day
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Rank in Stocks #20718
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Share Price
$0.00001
Market Cap
$50.01K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade MultiCell Technologies, Inc. (MCET)

Category

Stock price history for MultiCell Technologies, Inc. (MCET)
Highest end of day price: $0.00 on 2026-03-01

Lowest end of day price: $0.70 on 2000-01-01
Stock price history of MultiCell Technologies, Inc. from 2000 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 0.00%
2024 -76.06%
2023 -58.24%
2022 0.00%
2021 -58.10%
2020 156.99%
2019 -7.14%
2018 -41.18%
2017 -16.78%
2016 -6.37%
2015 -36.84%
2014 -38.00%
2013 -58.42%
2012 -72.33%
2011 13.46%
2010 -68.39%
2009 150.51%
2008 -86.27%
2007 -83.63%
2006 -60.50%
2005 -31.77%
2004 -70.68%
2003 719.22%
2002 -33.40%
2001 -14.26%
2000 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$38.37 -50.27%
DK
$465.49 -7.78%
US
$755.73 13.32%
US
$302.35 54.55%
BE
$99.21 -36.97%
AU